Divi's Laboratories Ltd
DIVISLABDivi's Laboratories Ltd
DIVISLAB
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 74.57 | 7.78 | 0.80% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.46 | 5.11 | 0.70% |
Forecast & Ratings
Detailed Forecastfrom 20 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.
Peers
Compare with peersSyngene International Ltd
Aarti Pharmalabs Ltd
Dishman Carbogen Amcis Ltd
Vimta Labs Ltd
Brooks Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,159.64 | 3,873.80 | 4,139.23 | 4,004.93 | 5,101.89 | 5,584.05 | 7,031.96 | 9,073.70 | 8,112.17 | 7,692.93 | ||||||||||
Raw Materials | 1,452.84 | 1,478.71 | 1,608.36 | 1,567.94 | 2,169.72 | 2,256.99 | 2,455.40 | 3,552.07 | 3,088.18 | 5,467.40 | ||||||||||
| Power & Fuel Cost | 170.82 | 180.34 | 198.80 | 228.73 | 248.78 | 280.73 | 319.15 | 392.33 | 496.61 | |||||||||||
| Employee Cost | 290.42 | 361.19 | 499.90 | 456.06 | 542.27 | 621.05 | 825.76 | 946.16 | 975.02 | |||||||||||
| Selling & Administrative Expenses | 129.32 | 134.18 | 154.26 | 200.48 | 175.70 | 228.23 | 287.84 | 345.20 | 398.36 | |||||||||||
| Operating & Other expenses | -94.72 | 203.61 | 155.88 | 175.53 | -63.23 | 184.21 | 220.08 | -159.07 | 440.23 | |||||||||||
EBITDA | 1,210.96 | 1,515.77 | 1,522.03 | 1,376.19 | 2,028.65 | 2,012.84 | 2,923.73 | 3,997.01 | 2,713.77 | 2,225.53 | ||||||||||
| Depreciation/Amortization | 136.00 | 118.18 | 123.33 | 142.49 | 168.90 | 186.24 | 255.59 | 311.51 | 343.18 | 361.77 | ||||||||||
| PBIT | 1,074.96 | 1,397.59 | 1,398.70 | 1,233.70 | 1,859.75 | 1,826.60 | 2,668.14 | 3,685.50 | 2,370.59 | 1,863.76 | ||||||||||
| Interest & Other Items | 2.88 | 4.74 | 3.36 | 2.37 | 4.68 | 7.14 | 2.10 | 2.00 | 1.96 | 1.13 | ||||||||||
| PBT | 1,072.08 | 1,392.85 | 1,395.34 | 1,231.33 | 1,855.07 | 1,819.46 | 2,666.04 | 3,683.50 | 2,368.63 | 1,862.63 | ||||||||||
| Taxes & Other Items | 220.55 | 267.06 | 334.92 | 354.32 | 502.33 | 442.92 | 681.75 | 723.05 | 545.25 | 530.83 | ||||||||||
| Net Income | 851.53 | 1,125.79 | 1,060.42 | 877.01 | 1,352.74 | 1,376.54 | 1,984.29 | 2,960.45 | 1,823.38 | 1,331.80 | ||||||||||
| EPS | 32.08 | 42.41 | 39.95 | 33.04 | 50.96 | 51.85 | 74.75 | 111.52 | 68.69 | 50.17 | ||||||||||
| DPS | 10.00 | 10.00 | 10.00 | 10.00 | 16.00 | 16.00 | 20.00 | 30.00 | 30.00 | 30.00 | ||||||||||
| Payout ratio | 0.31 | 0.24 | 0.25 | 0.30 | 0.31 | 0.31 | 0.27 | 0.27 | 0.44 | 0.60 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Divi's Laboratories Ltd | 54.47 | 7.78 | 0.80% |
| Syngene International Ltd | 63.18 | 8.11 | 0.17% |
| Aarti Pharmalabs Ltd | 22.09 | 2.74 | — |
| Dishman Carbogen Amcis Ltd | -85.52 | 0.44 | — |
Price Comparison
Compare DIVISLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Divi's Laboratories Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
SBI Equity Hybrid Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.3882% | Percentage of the fund’s portfolio invested in the stock 4.00% | Change in the portfolio weight of the stock over the last 3 months 0.21% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/100 (-10) |
SBI Focused Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.4670% | Percentage of the fund’s portfolio invested in the stock 4.97% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/31 (0) |
AXIS LONG TERM EQUITY FUND DIRECT PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.3023% | Percentage of the fund’s portfolio invested in the stock 4.15% | Change in the portfolio weight of the stock over the last 3 months -0.62% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/45 (-1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
DIVISLAB has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.79%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.90 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 11, 2023
Dividend/Share
₹30.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 11, 2022
Dividend/Share
₹30.00
Ex DateEx Date
Aug 11, 2022
Cash Dividend
Ex DateEx DateAug 17, 2021
Dividend/Share
₹20.00
Ex DateEx Date
Aug 17, 2021
Cash Dividend
Ex DateEx DateFeb 25, 2020
Dividend/Share
₹16.00
Ex DateEx Date
Feb 25, 2020
Cash Dividend
Ex DateEx DateAug 14, 2019
Dividend/Share
₹16.00
Ex DateEx Date
Aug 14, 2019
News & Opinions
News Video
Sensex Drops 200 Pts, Nifty Below 19,400; JK Lakshmi, Divi's Lab Shed 3% Each | Opening Bell
4 weeks ago•ET NOW
News Video
Sanjiv Bhasin's Pharma Sector Analysis And Small-Cap Investment Recommendations
4 weeks ago•ET NOW
News Video
Q2 Preview: What Can Investors Expect From Divi's Laboratories' Earnings? | BQ Prime
1 month ago•BQ Prime
Indian Stock Market Sees Decline At Closing Amid Pessimism
2 months ago•Zee News
News Video
Pharma Stocks Outperform On Stock Market | Divi's Lab, Nifty Pharma | Deepak Shenoy
3 months ago•ET NOW
Taking Stock: Last-hour buying pushes Nifty above 19,600, Sensex up 149 points
3 months ago•Moneycontrol
Taking Stock: Sensex, Nifty end lower as investors turn cautious in data-heavy week
3 months ago•Moneycontrol
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 15.16%, vs industry avg of 8.01%
Increasing Market Share
Over the last 5 years, market share increased from 37.72% to 46.1%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 15.76%, vs industry avg of 15.02%